🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Several professionals stated the demand for the experimental drug could be connected to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on social media or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Some content creators try to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or prison.

Service Reaction and Content Elimination

According to the social media company, the platform has taken down violative content and banned associated keywords and search suggestions. The company stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Investigations also found groups with up to 9,000 participants selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or injecting at home.

Within moments of joining one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Information and Costs

Within these groups, messages show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how much time a pen should last, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Actions

A representative for the messaging service said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to possibly serious medical dangers”.